The HCPLive migraine page is a comprehensive resource for clinical news and insights on migraine headaches. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for migraines, and more.
March 14th 2023
Data from a phase 2 randomized clinical trial demonstrate use of the GLP-1 receptor agonist exenatide could be used as a treatment for idiopathic intracranial hypertension in women.
Self-Prediction of Headaches, Stress Letdown Are Targets for Early Migraine Intervention
May 2nd 2014For many migraine sufferers, current strategies to treat headaches, or to prevent their occurrence, are insufficient to ward off the near-daily occurrence of head pain, prompting researchers to investigate methods of pre-emptive migraine treatment.
Long-term Botox Treatment Sustains Prevention of Chronic Migraine Headaches
Although the benefit of Botox (onabotulinumtoxinA) for preventing headaches in adults with chronic migraine has been extensively established in clinical trials, limited data exists on the injections' effectiveness for the indication beyond 5 treatment cycles.
Pain Experts Poke Holes in Published Clinical Treatment Guidelines
Although they have all participated in the development of treatment guidelines for a variety of pain conditions, 3 comprehensive pain experts openly acknowledged and discussed the practical limitations of published evidence-based recommendations during the closing session of the American Academy of Pain Medicine 2014 Annual Meeting.
FDA Panel Votes Against Naproxen's Cardiovascular Safety Claim
A US Food and Drug Administration (FDA) advisory panel has not found enough clinical evidence to conclude that naproxen presents a lower risk of cardiovascular (CV) thrombotic events than other nonsteroidal anti-inflammatory drugs (NSAIDs).
New Program Needed to Track Concussions in Youth
A new report from the Institute of Medicine (IOM) calls for a national surveillance program that will help create enough data on concussions in young athletes to counter the lack of information on the phenomenon, as well as resist what the agency calls "a culture of resistance" pervading youth sports.
High Rates of Neuroimaging in Outpatient Headache Visits
October 16th 2013Despite current guideline recommendations against the use of routine neuroimaging for uncomplicated headaches, physicians still tend to order imaging tests for many patients who present with headache and migraine, driving up annual healthcare spending.
Researchers Measure Complex Migraine Aura Duration, Recommend Disorder Category Change
Though the third edition of the International Classification of Headache Disorders (ICHD-III) proposes to label aura in non-hemiplegic migraine that lasts longer than one hour but shorter than one week as probable migraine with aura - or probable complex migraine - a group of researchers from Italy, Switzerland, Germany, and California decided to analyze clinical studies to determine whether or not that timeframe aligns with the typical duration of migraine aura.
Medication Overuse Headache: When the Cure is the Cause of the Pain
August 10th 2012Also known as rebound headache, medication overuse headache is a fairly common condition that can be missed by non-specialists who are unfamiliar with its presentation and clinical signs. This article reviews the causes and types of medication overuse headache and discusses the current thinking on treatment.
Persistent Pediatric Pain: New Paradigms, Improved Prognoses
February 20th 2012In recent years, physicians' thinking has changed when it comes to evaluating pain in patients. Now, rather than looking at pain as being merely a symptom of an underlying disorder, many clinicians are now focusing on the pain itself, and changing their approach to how they treat it.
Reliable Online Resources on OTC Analgesics for Patients
December 19th 2011With so much health care information online, it can be hard sometimes for patients to tell which websites and resources provide reliable and accurate information, especially when it comes to complex topics such as the risks and benefits of different OTC options for pain.
Know Your Herbs and Supplements!
December 16th 2011There are many herbs and supplements on the market that are thought to be effective by some patients and practitioners for managing pain. However, for many of these herbs and supplements, there is little in the way of reliable evidence supporting these claims. Nonetheless, millions of patients may be using these agents to supplement the pain care provided by their physicians and other clinicians, often without informing them of this fact.
Identifying the Great Masquerader: Diagnosing Migraine in Primary Care
December 5th 2011Studies have shown that primary care physicians as a group need more training and education to better prepare them to accurately diagnose and treat migraine, which remains one of the most misunderstood forms of headache, despite its heavy burden on patients in the US.